Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : TAVA Technologies (TAVA-NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: E who wrote (8244)	1/2/1998 7:13:00 PM
From: Andrew H	Respond to of 31646

>> Somebody finally brought up the words "embedded chips" and "diagnosis"! Excellent! << I am new to the study of the YK2 problem, but it seems to me that initially the YK2 software code problem encountered the same denial, disbelief and ignorance that the embedded system problem is now dealing with. Now we are talking about worldwide costs up to $1000 Billion. Just as the more general YK2 problem is now becoming the top financial story of the New Year, so there will be many converts who will come to believe in the reality of the embedded systems problem. We are just now BEGINNING to hear about embedded systems in the media, so one can logically assume TPRO to have at least similar (and likely much greater growth, since it is the only major player addressing the problem) growth to companies like IMRS, MAST, KEA, etc. Clearly this lag in problem recognition is the reason that TPRO can still be bought for less than $10/share. One more large contract announcement like BMY (maybe next week as some have suggested) and the final nagging doubts will be removed. Put this together with marginability and TPRO's first profitable quarter, and the double digit estimates we have seen on the thread for January/February could become a reality. At that point it is easy to imagine a couple of large brokerage house come out with buy recs....